Cleared Traditional

K231576 - cNeuro cPET

K231576 is an FDA 510(k) clearance for cNeuro cPET, manufactured by Combinostics OY. The device is a Class 2 Radiology device with product code KPS cleared through the Traditional 510(k) pathway after a 106-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2023
Decision
106d
Days
Class 2
Risk

K231576 is an FDA 510(k) clearance for the cNeuro cPET. Classified as System, Tomography, Computed, Emission (product code KPS), Class II - Special Controls.

Submitted by Combinostics OY (Tampere, FI). The FDA issued a Cleared decision on September 14, 2023 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1200 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Combinostics OY devices

FDA 510(k) Submission Details - K231576

510(k) Number K231576 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 31, 2023
Decision Date September 14, 2023
Days to Decision 106 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 107d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KPS Device Classification - Class 2, Special Controls

Product Code KPS System, Tomography, Computed, Emission
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

RQM+
Erin Gontang

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KPS System, Tomography, Computed, Emission

All 249
Devices cleared under the same product code (KPS) and FDA review panel - the closest regulatory comparables to K231576.
Biograph VK10
K233677 · Siemens Medical Solutions USA, Inc. · Jan 2024
uMI Panorama
K232712 · Shanghai United Imaging Healthcare Co., Ltd. · Oct 2023
CAREMIBRAIN
K232569 · General Equipment For Medical Imaging, S.A. · Sep 2023
Cartesion Prime (PCD-1000A/3) V10.15
K231748 · Canon Medical Systems Corporation · Sep 2023
Optional Screen Displays for HeartSee Cardiac P.E.T. Processing Software - HeartSee version 4
K231731 · Mcgovern Medical School · Aug 2023
uMI Panorama
K231572 · Shanghai United Imaging Healthcare Co., Ltd. · Jul 2023